Trince

Asse, Belgium

Trince is advancing cell-based science and therapeutics by facilitating the delivery of molecules into cells, both in vitro and ex vivo.

$6.1M raised

Jan 2026

Undisclosed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Trince raised?

Trince has raised $6.1M in total funding. The most recent round was Undisclosed. The last funding was announced in January 2026.

Who are Trince's investors?

Trince's investors include Novalis Biotechnology Incubation, Qbic Fund.

Where is Trince headquartered?

Trince is headquartered in Asse, Belgium.

What does Trince do?

Trince is advancing cell-based science and therapeutics by facilitating the delivery of molecules into cells, both in vitro and ex vivo.

What stage is Trince at?

Trince is at the Undisclosed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 20, 2026.

MLA

"Trince — Funding & Investors." VCBacked, January 20, 2026, https://www.vcbacked.co/company/trince. Accessed July 2, 2026.

APA

VCBacked. (2026). Trince — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/trince

Wikipedia (cite web)

{{cite web |title=Trince — Funding & Investors |url=https://www.vcbacked.co/company/trince |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 20, 2026.